Moderna (MRNA) reaffirms plan to break even by 2028 with 2026 revenue growth of up to 10%

Observed price moves

• MRNA+1.10%10 min after this headline

MoveSurge carries market-moving headlines the moment they reach the wire, each one with what the price did next.